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Identification of protein disulfide isomerase 1 
as a key isomerase for disulfide bond formation 
in apolipoprotein B100
Shiyu Wanga, Shuin Parka, Vamsi K. Kodalia, Jaeseok Hanb, Theresa Yipa, Zhouji Chenc, 
Nicholas O. Davidsond, and Randal J. Kaufmana
aDegenerative Diseases Research Program, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037; 
bSoonchunhyang Institute of Med-Bio Science, Soonchunhayng University, Cheonan-si, Choongchengnam-do 
330-930, Republic of Korea; cDivision of Geriatrics and Nutrition Sciences and dDivision of Gastroenterology, 
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110
ABSTRACT Apolipoprotein (apo) B is an obligatory component of very low density lipopro-
tein (VLDL), and its cotranslational and posttranslational modifications are important in VLDL 
synthesis, secretion, and hepatic lipid homeostasis. ApoB100 contains 25 cysteine residues 
and eight disulfide bonds. Although these disulfide bonds were suggested to be important 
in maintaining apoB100 function, neither the specific oxidoreductase involved nor the direct 
role of these disulfide bonds in apoB100-lipidation is known. Here we used RNA knockdown 
to evaluate both MTP-dependent and -independent roles of PDI1 in apoB100 synthesis and 
lipidation in McA-RH7777 cells. Pdi1 knockdown did not elicit any discernible detrimental 
effect under normal, unstressed conditions. However, it decreased apoB100 synthesis with 
attenuated MTP activity, delayed apoB100 oxidative folding, and reduced apoB100 lipida-
tion, leading to defective VLDL secretion. The oxidative folding–impaired apoB100 was se-
creted mainly associated with LDL instead of VLDL particles from PDI1-deficient cells, a phe-
notype that was fully rescued by overexpression of wild-type but not a catalytically inactive 
PDI1 that fully restored MTP activity. Further, we demonstrate that PDI1 directly interacts 
with apoB100 via its redox-active CXXC motifs and assists in the oxidative folding of apoB100. 
Taken together, these findings reveal an unsuspected, yet key role for PDI1 in oxidative fold-
ing of apoB100 and VLDL assembly.
INTRODUCTION
Secretion of very low density lipoprotein (VLDL) from the liver is vital 
for maintaining circulating lipid homeostasis (Hamilton, 1972). Over-
production of hepatic VLDL particles is a common cause of systemic 
hyperlipidemia in humans, a high risk factor of cardiovascular dis-
ease in obesity and type 2 diabetes (Adiels et al., 2008). The funda-
mental cellular mechanism(s) that drive lipid-rich VLDL assembly are 
not fully understood (Sundaram and Yao, 2010).
Hepatic VLDL is secreted as a spherical particle containing a 
requisite structural protein, apolipoprotein B (apoB), which binds 
with different lipid species, mainly bulk neutral lipids, especially 
triglycerides (TGs; Yang et al., 1995). ApoB is synthesized by 
cotranslational lipidation in the rough endoplasmic reticulum (rER; 
Rutledge et al., 2010) and undergoes further posttranslational lipi-
dation within the smooth ER (sER) lumen. Both cotranslational and 
posttranslational lipidations of apoB are mediated by the resident 
ER heterodimeric microsomal triglyceride transfer protein (MTP) 
complex, which comprises a large subunit (MTP) and a smaller 
subunit, protein disulfide isomerase 1 (PDI1; Wetterau et al., 
1991). Previous genetic studies demonstrated that the large 
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infects hepatoma cells with high efficiency, ensuring effective knock-
down of target genes. Accordingly, Pdi1 mRNA levels were de-
creased by >95%, and PDI1 protein levels were almost undetectable 
in Hepa1-6 cells 3 d after adenoviral infection (confirmed with two 
sets of shRNAs; Supplemental Figure S1, A and B). For the purposes 
of this article, all studies were conducted with shRNA 1. Adenovirus-
mediated Pdi1 knockdown was then tested in McA-RH7777 (McA) 
rat hepatoma cells, a widely used model for studying hepatic lipo-
protein secretion (Boren et al., 1994; Liang et al., 2004; Yamaguchi 
et al., 2003). McA cells secrete predominantly apoB100 in VLDL par-
ticles with size and density distribution similar to that of human he-
patocytes (Boren et al., 1994). Pdi1 mRNA and protein levels were 
decreased ∼80% after shRNA-mediated knockdown in McA cells 
(Figure 1, A and B). Moreover, knockdown of Pdi1 did not lead to 
compensatory up-regulation or off-target knockdown of other PDI 
family members, including ERp57 and ERp72 (Figure 1A and Sup-
plemental Figure S1A) in both Hepa1-6 and McA cells. In addition, 
the Pdi1 knockdown mediated by adenovirus persisted at least 8 d 
after infection, allowing adequate time to perform the functional 
studies in Pdi1-knockdown cells (Supplemental Figure S2). These 
findings gave us confidence that our approach allows us to examine 
the phenotypes associated with Pdi1 knockdown in McA cells.
Because PDI1 is proposed to be an important ER protein chaper-
one and disulfide isomerase, we first tested whether Pdi1 knock-
down disturbs ER homeostasis to activate the unfolded protein re-
sponse (UPR) in either Hepa1-6 or McA cells. Our analyses revealed 
no significant changes in mRNA abundance for spliced Xbp1 or 
other ER chaperones, suggesting that the UPR is not activated upon 
Pdi1 knockdown in Hepa1-6 and McA cells (Figure 1A and Supple-
mental Figure S1A). However, after exposure to the ER stress in-
ducer tunicamycin (Tm) or thapsigargin (Tg), we observed that Pdi1-
knockdown cells (Hepa1-6 or McA cells) were more sensitive to ER 
stress, as indicated by decreased cell survival and increased levels of 
cleaved caspase 3 and PARP (Figure 1, C–E, and Supplemental 
Figure S1, C–E). Moreover, Pdi1 knockdown increased phosphoryla-
tion of eukaryotic initiation factor 2α (eIF2α) in response to Tg-in-
duced ER stress and induced expression of C/EBP homologous pro-
tein (CHOP), a major UPR mediator of apoptosis, in both cell lines 
(Figure 1, C–E, and Supplemental Figure S1, C–E). Thus knockdown 
of Pdi1 increased sensitivity of cells to agents that cause ER stress.
To determine whether PDI deficiency alters the ER redox bal-
ance, which, in turn, affects ER homeostasis and oxidative protein 
folding, we generated McA cells that stably express in situ sensor 
molecules—green fluorescent protein (GFP) iE variant fused to ER-
localized glutaredoxin-1 (Grx-roGFP-iEER; Birk et al., 2013). Grx-
roGFP-iEER exists in reduced and oxidized forms, which reflect the 
redox status of the ER. We performed dithiothreitol (DTT) recovery 
experiments in PDI-deficiency cells to determine the oxidation po-
tential as described in Materials and Methods. These experiments 
revealed that despite its demonstrated role as a major oxi-
doreductase in the ER (Appenzeller-Herzog et al., 2010), PDI1 
knockdown did not change the redox status of Grx-roGFP-iEER 
(Figure 1F). We interpret these results to suggest that PDI1 knock-
down does not cause systemic redox imbalance in the ER (Figure 
1F). Taken together, the results indicate the knockdown of Pdi1 does 
not significantly alter ER homeostasis under normal conditions but 
sensitizes cells to ER stress–induced cell death.
Knockdown of PDI1 decreases apoB100 synthesis 
and secretion in McA cells
We next examined protein levels of apoB100 and MTP and found 
that Pdi1 knockdown drastically decreased intracellular apoB100 
maturation, and secretion (Raabe et al., 1999). However, the role 
of PDI1 as a subunit of MTP complex in apoB synthesis and lipida-
tion remains to be elucidated.
Each VLDL particle contains a single apoB molecule, in one of 
two forms, either apoB100 (the full-length protein) or apoB48 (the 
N-terminal 48% of apoB100). The two forms are encoded by the 
same ApoB gene, but RNA editing modifies ApoB mRNA at codon 
2153, which converts a glutamine codon to a stop codon, giving rise 
to apoB48 (Blanc and Davidson, 2011). ApoB100 is the only form in 
human liver, although both apoB100 and 48 are present in rodent 
livers (Blanc and Davidson, 2003). ApoB100 is a large hydrophobic 
protein, with molecular weight >500 kDa (Gibbons et al., 2004). 
Folding of apoB is a complex process, involving an array of protein 
chaperones and posttranslational modifications including lipidation, 
glycosylation, and disulfide bond formation (Burch and Herscovitz, 
2000). ApoB100 that fails to fold into its mature form is directed to 
proteasomal and/or autophagy-mediated degradation (Liao et al., 
2003).
PDI1 is a resident foldase containing two redox-active thiore-
doxin domains that catalyze the formation and isomerization of dis-
ulfide bonds during protein folding in the ER. PDI1 was identified 
>35 years ago (Carmichael et al., 1977) and has been extensively 
studied in vitro (Hatahet and Ruddock, 2009). Biochemical studies 
with model substrates demonstrated that PDI1 increases the rate of 
disulfide bond formation without changing the protein-folding path-
way (Bulleid and Freedman, 1988; Hatahet and Ruddock, 2009). In 
addition to being a molecular chaperone of MTP, PDI1 exhibits anti-
aggregation as well as antichaperone activities (Puig and Gilbert, 
1994; Sideraki and Gilbert, 2000) in a concentration- and calcium-
dependent manner that does not require its thiol-redox activity 
(Primm et al., 1996). Recent studies suggest that PDI retards disul-
fide bond formation and secretion of proinsulin (Rajpal et al., 2012). 
In addition, a requirement for PDI1 was demonstrated for reduction 
in infectivity of cholera toxin (Moore et al., 2010). However, it re-
mains unknown whether PDI1 is required to promote oxidation of 
any substrate in vivo.
Previous studies demonstrated that disulfide bonds are required 
for folding and secretion of apoB100. ApoB100 contains 25 cysteines 
that form eight disulfide bonds that are largely clustered within the 
amino terminus (Shelness and Thornburg, 1996). Because apoB100 
is a large protein and most of its disulfide bonds are formed be-
tween adjacent cysteine residues, it was believed that the shift in the 
migration of the disulfide-bonded form compared with its reduced 
form is practically undetectable (Burch and Herscovitz, 2000); there-
fore it remains unknown whether any or multiple PDI family mem-
bers catalyze apoB100 disulfide bond formation in vivo. In this study, 
we successfully distinguished the disulfide-bonded form of apoB100 
from its completely reduced form by electrophoresis on 5% poly-
acrylamide gels. We found that the smaller subunit of the MTP com-
plex, PDI1, plays a key role in promoting disulfide bond formation 
within apoB100. Our data suggest that physiological lipidation of 
apoB100 requires correct disulfide bond formation in apoB100, 
which is mediated by PDI1. Taken together, our findings demon-
strate an unsuspected role of PDI1 as a requisite disulfide isomerase 
for apoB100 processing.
RESULTS
Knockdown of PDI1 sensitizes cells to ER stress without 
altering ER homeostasis
To study the functional role of PDI1 in hepatic VLDL assembly, we 
first generated adenoviruses expressing Pdi1 short hairpin RNAs 
(shRNAs) to knock down PDI1 in rodent hepatoma cells. Adenovirus 
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cells. ApoB synthesis was significantly reduced by Pdi1 knockdown 
at each time point tested, indicating that Pdi1 knockdown attenu-
ates full-length apoB synthesis (Supplemental Figure S3A). We also 
performed pulse-chase analyses to compare rates of apoB secretion 
and synthesis in the presence or absence of PDI1. As shown in the 
pulse-labeling experiments, Pdi1- knockdown McA cells synthesized 
∼50% less apoB100 than control cells, and the secretion of apoB100 
was also proportionally decreased (Figure 2C and Supplemental 
Figure S3B). However, overall apoB100 recovery rates were not 
levels by ∼50% without altering its mRNA expression. Pdi1 knock-
down had a relatively milder effect on MTP, with a ∼20% decrease in 
steady-state protein levels (Figure 2, A and B). Nonetheless, these 
observations indicate that PDI1 plays an essential role in maintain-
ing intracellular apoB100 levels.
To determine how PDI1 expression affects the steady-state level 
of apoB100 protein, we first performed pulse-labeling experiments 
to monitor apoB synthesis using [35S]methionine/cysteine (Met/Cys) 
over a 25-min time course in control and PDI1-knockdown McA 
FIGURE 1: Knockdown of Pdi1 sensitizes cells to ER stress. (A, B) Adenoviral expression of Pdi1 shRNA knocks down 
PDI1 levels in McA cells. (A) Relative abundance of mRNA expressed in control (NSi) and Pdi1-knockdown (PDI1i) cells. 
mRNA levels were normalized to actin levels. Values are relative to mRNA levels of control cells. *p < 0.01 vs. NSi. 
(B) PDI1 protein levels in control (NSi) and Pdi1-knockdown (PDI1i) cells. Cell lysates were subjected to immunoblotting 
analyses using PDI1 and vinculin antibodies. (C–E) Pdi1-knockdown cells are more sensitive to ER stress. (C, D) Cell 
survival was measured by cell counting after treatment with different concentration of Tm or Tg. *p < 0.01 vs. NSi in the 
same treatment group. (E) Protein levels of ER stress markers in control (NSi) and Pdi1-knockdown (PDI1i) cells. Cells 
were treated with 0.2 μM Tg for indicated time periods, and cell lysates were immunoblotted for cleaved caspase 3, 
PARP, eIF2α-P, CHOP, and BiP. (F) ER redox balance is not altered in Pdi1-knockdown cells. Cells expressing Grx-roGFP-
iEER were treated with 10 mM DTT for 10 min and washed out. The oxidation status of Grx-roGFP-iEER was analyzed by 
nonreducing SDS–PAGE and immunoblotting with GFP, KDEL (GRP78 and GRP94), and PDI antibodies.
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FIGURE 2: Knockdown of Pdi1 decreases apoB synthesis and secretion in McA cells. (A, B) Pdi1 knockdown in McA cells 
reduces apoB100 protein but not mRNA levels. (A) Relative abundance of apoB and MTP mRNAs in control (NSi) and 
Pdi1-knockdown (PDI1i) cells. Relative abundance was normalized to actin mRNA levels. Values are relative to mRNA 
levels of control cells. *p < 0.01 vs. NSi (B) ApoB100 and MTP protein levels in control (NSi) and Pdi1-knockdown (PDI1i) 
cells. Cell lysates were immunoblotted for PDI1, apoB100, MTP, and actin. (C) Pdi1-knockdown (PDI1i) in McA cells 
reduces apoB100 synthesis and secretion. Pulse-chase analysis of intracellular and secreted apoB100 was performed in 
control (NSi) and Pdi1-knockdown (PDI1i) McA cells. Double asterisks represent a nonspecific band. (D) Proteasomal 
degradation reduces apoB100 levels in McA cells. Pulse-chase analysis of intracellular apoB100 and secreted apoB was 
performed in control (NSi) and Pdi1-knockdown (PDI1i) McA cells in the absence (control) or presence of 10 μM MG132. 
(E) The amount of apoB100 in intracellular and secreted fractions was quantified by ImageJ. Recovery rates of apoB100 
are presented as percentage of the sum of apoB100 (intracellular plus secreted) over total apoB100 at zero time point 
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activity. Because the chaperone activity of PDI1 is independent of 
its isomerase activity (Wang et al., 1997), we next determined the 
extent to which the decreased apoB lipidation was due to reduced 
MTP activity in Pdi1-knockdown cells. For this purpose, we deliv-
ered adenoviruses expressing either wild-type human PDI1 or a 
catalytically inactive PDI1 in which all four redox-active cysteines 
are mutated to alanines (Uehara et al., 2006) into Pdi1-knockdown 
cells. These experiments revealed that expression of either wild-
type or catalytically inactive PDI1 fully restored MTP activity, yet 
TG secretion was only partially restored by the catalytically inac-
tive PDI1 in Pdi1-knockdown cells (Figure 3, G–I). In addition, we 
conducted pulse-chase experiments to measure apoB secretion in 
Pdi1-knockdown cells in which we rescued expression with either 
wild-type PDI1 or a catalytically inactive PDI1. These results 
showed that overexpression of the wild-type but not the catalyti-
cally inactive PDI1 restored apoB secretion in the PDI1-knockdown 
McA cells (Supplemental Figure S4), which is consistent with the 
findings regarding TG secretion. Therefore, from both apoB 
secretion and TG secretion experiments, we conclude that the 
secretion of apoB is at least in part dependent on catalytic oxi-
doreductase activity of PDI1 in McA cells. These findings suggest 
that PDI1 exerts an additional MTP-independent role in apoB syn-
thesis, lipidation, and/or secretion (Figure 3, G–I).
Pdi1 knockdown decreases apoB100 oxidative folding 
in McA cells
Previous work suggested that the oxidoreductase activity of PDI1 
is required for MTP-independent steps of apoB100 synthesis and 
secretion (Wang et al., 1997). To explore this possibility in more 
detail, we used pulse-chase experiments in which newly synthe-
sized proteins were resolved by nonreducing gel electrophoresis 
to allow us to test whether Pdi1 knockdown modifies apoB disul-
fide bond formation. We found that intracellular and secreted 
apoB100 migrated more slowly at the later chase time points in 
Pdi1-knockdown cells, raising the possibility that disulfide bond 
formation is delayed for newly synthesized apoB100 (Figure 4A, 
asterisk). To our surprise, apoB100 with partially oxidized disulfide 
bonds were also secreted in Pdi1-knockdown cells, suggesting 
that these apoB100 molecules undergo sufficient lipidation to at-
tenuate posttranslational degradation.
To compare further the kinetics of apoB100 disulfide bond for-
mation between control and Pdi1 knockdown cells, we synchro-
nized protein synthesis by puromycin pretreatment before the 
pulse-chase experiments. In addition, we used N-ethylmaleimide 
(NEM) to alkylate free thiols to prevent postlysis alterations in disul-
fide bonds. Furthermore, because apoB100 synthesis is decreased 
in Pdi1-knockdown cells, in order to have comparable levels of 
apoB100 to study apoB100 disulfide bond formation in both cells, 
we used more lysates from Pdi1- knockdown cells to conduct these 
experiments. First, we analyzed apoB100 on both reducing and 
nonreducing gels and demonstrated that the oxidized form of 
apoB100 (Ox in Figure 4B) migrated with greater mobility than the 
fully reduced form of apoB100 (Re in Figure 4B). Second, analysis of 
reducing gels demonstrated that the migration of apoB100 from 
control and Pdi1-knockdown cells was comparable, suggesting that 
the difference in migration is due to cysteine oxidation and not to 
another posttranslational modification (Figures 4, B [darker in Sup-
plemental Figure S4] and D, and 5C). Furthermore, almost all of the 
intracellular apoB100 matured to the oxidized form upon transla-
tion in control cells, whereas a significant portion of apoB100 
remained only partially oxidized until the end of the chase period in 
Pdi1-knockdown cells (Figure 4B).
significantly different in these two cell lines (Supplemental Figure 
S3B), suggesting that posttranslational degradation of apoB100 is 
not accelerated in Pdi1-knockdown cells. In addition, the decrease 
in apoB100 synthesis was not due to a general decrease in protein 
synthesis (unpublished data). These observations suggest that PDI1 
is important for the synthesis of full-length apoB100.
Because endogenous apoB100 is constitutively degraded 
cotranslationally (Pan et al., 2008), it was important to address the 
question of whether apoB cotranslational degradation reduces the 
cellular recovery of apoB100 in Pdi1-knockdown cells. Accordingly, 
we performed pulse-chase experiments in cells treated with MG132 
to inhibit proteasome-mediated protein degradation. Indeed, 
MG132 stabilized intracellular accumulation of apoB100 in both 
control and Pdi1-knockdown cells based on the quantification re-
sults (Figure 2, D and E), indicating that a portion of apoB100 is 
subject to cotranslational degradation by the proteasome. However, 
compared with control cells, Pdi1-knockdown cells still contained 
significantly less labeled apoB100, suggesting that either apoB syn-
thesis is compromised and/or nascent apoB undergoes nonprotea-
somal degradation in Pdi1-knockdown cells. These observations 
together suggest that PDI1 is important for apoB100 synthesis and 
stabilization.
Knockdown of PDI1 decreases apoB100 lipidation 
in McA cells
Poorly lipidated nascent apoB100 is readily degraded cotranslation-
ally in a proteasome-dependent and/or -independent manner (Pan 
et al., 2008). To determine whether Pdi1 knockdown disrupts lipida-
tion of apoB, we analyzed the density distribution of apoB100 par-
ticles secreted from control and Pdi1-knockdown cells. Cells were 
labeled continuously for 3 h with [35S]Met/Cys, and the labeled me-
dium was subjected to density gradient ultracentrifugation (DGUC) 
to separate apoB100-containing particles based on their relative hy-
drated density. ApoB100-containing particles secreted from control 
cells migrated primarily in the VLDL fractions (fractions 1 and 2; 
Figure 3, A and B) either in the presence or absence of oleic acid in 
the media. In contrast, most of the apoB100-containing particles se-
creted from Pdi1 knockdown cells were distributed as low-density 
lipoproteins (fractions 3–6; Figure 3, A and B). We interpret this shift 
to suggest that the relative distribution of apoB100 in the lipid-rich 
VLDL fractions from Pdi1-knockdown cells was decreased, whereas 
the proportion of apoB100 migrating in lipid-poor particles corre-
spondingly increased. In contrast to apoB100, apoB48 was mainly 
associated with the lipid-poor particles and was not altered by Pdi1 
knockdown in McA cells (Figure 3, A and B). This result indicates that 
PDI1 is required for full lipidation of apoB100 and VLDL maturation.
ApoB is the major carrier of TG secreted from hepatocytes, and 
therefore decreased apoB100 lipidation can directly decrease TG se-
cretion in McA cells upon Pdi1 knockdown. To confirm that Pdi1 
knockdown reduces TG secretion without altering TG synthesis, we 
measured TG synthesis and secretion by labeling cells with [3H]glyc-
erol, followed by thin-layer chromatography (TLC) analyses. Analysis 
of intracellular TG levels indicated that TG synthesis was not altered, 
whereas TG secretion decreased >40% upon Pdi1 knockdown (Figure 
3E). This observation is consistent with the finding that Pdi1-knock-
down cells secrete apoB in lipid-poor particles (Figure 3, A and B).
Because PDI1 is a molecular chaperone for MTP, we next asked 
whether Pdi1 knockdown might decrease MTP activity to limit 
apoB lipidation. Indeed, MTP activity in Pdi1-knockdown McA 
cells decreased by >50% (Figure 3F). Thus our results indicate that 
PDI1 is required for McA cells to assemble and/or secrete lipid-
rich apoB100 VLDL particles, at least in part, by maintaining MTP 
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FIGURE 3: Knockdown of Pdi1 decreases apoB100 lipidation in McA cells. (A–D) Pdi1 knockdown reduces apoB100 
lipidation. McA cells were continuously labeled with [35S]Met/Cys containing BSA (A) or 400 μM OA (C) for 4 h. The 
medium was collected for determination of buoyant density of secreted apoB-containing lipoproteins from control (NSi) 
and Pdi1 knockdown (PDI1i) McA cells by DGUC, followed by immunoprecipitation for apoB100. The amount of 
apoB100 in each fraction was quantified by ImageJ. Relative distributions were calculated according to the percentage 
of apoB100 in each fraction relative to its total intensity across the gel (B, D). (E, F) Efficient TG secretion requires 
catalytically active PDI1. TG secretion (E) and MTP activity (F) were decreased in Pdi1-knockdown McA cells. TG 
synthesis and secretion (E) and MTP activity (F) were measured in control and Pdi1-knockdown McA cells. *p < 0.01 vs. 
NSi. (G–I) Overexpression of human wild-type PDI1 but not catalytically inactive PDI1 rescues decreased TG secretion in 
Pdi1-knockdown McA cells. (G) Wild-type and mutant PDI1 are expressed at equal levels in Pdi1-knockdown McA cells. 
β-Galactosidase (β-gal), human wild-type PDI1 (PDI), and catalytically inactive PDI1 (PDImu) were expressed using 
adenoviruses, and their expression levels were measured by Western blotting analysis. TG synthesis and secretion 
(H) and MTP activity (I) were measured in control cells or Pdi1-knockdown cells with overexpression of β-gal, PDI, or 
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essential for oxidative folding of these two proteins in HepG2 
cells (Rutkevich et al., 2010). Nevertheless, our preliminary obser-
vations in McA cells are consistent with this report (Rutkevich 
et al., 2010). Taken together, our results indicate that Pdi1 knock-
down selectively delays apoB100 oxidative folding, indicating 
that PDI1 serves as a disulfide isomerase specifically for 
apoB100.
In contrast to apoB100, the oxidative folding of other secre-
tory proteins, including albumin and transferrin, was not altered 
in Pdi1-knockdown cells during the time course of our pulse-
chase experiments (Figure 4B). We did not specifically investigate 
the disulfide bond formation of albumin and transferrin in a 
shorter time course of pulse-chase experiment in Pdi1- knock-
down cells since it was previously demonstrated that PDI1 is not 
FIGURE 4: Knockdown of Pdi1 decreases apoB100 oxidative folding in McA cells. (A) Pdi1 knockdown decreases 
oxidative folding of apoB100. Pulse-chase analysis of intracellular and secreted apoB100 in control (NSi) and Pdi1-
knockdown (PDI1i) McA cells by nonreducing gel electrophoresis. The bracket indicates both oxidized and reduced 
form of apoB100 in nonreducing gel. (B) Pdi1-knockdown selectively reduces oxidative folding of apoB100. Oxidative 
folding of intracellular apoB100, albumin, and transferrin were measured by reducing (first two lanes) and nonreducing 
gel electrophoresis. Ox, oxidized form, and Re, reduced form, of the protein. (C) Oxidative folding of apoB100 requires 
catalytically active PDI1. Oxidative folding of intracellular apoB100, albumin, and transferrin was measured by 
nonreducing gel electrophoresis in control (NSi) cells, Pdi1-knockdown (PDI1i) and Pdi1-knockdown (PDI1i) cells with 
exogenous expression of HA-tagged substrate-trap mutant (huPDImu) or wild-type (huPDI) human PDI1. (D) Oxidative 
folding of apoB100 does not require MTP activity. Oxidative folding of intracellular apoB100 and albumin were analyzed 
by nonreducing gel electrophoresis in the absence or presence of an MTP inhibitor (CP-10447) at 0, 0.3, or 3 μM.
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avenues to treat hyperlipidemia and related diseases. Although 
the large subunit of MTP complex is known to be important for 
apoB100 lipidation (Kulinski et al., 2002), the role of the small sub-
unit, PDI1, is not fully understood. PDI1 is generally believed to 
serve a chaperone function for MTP and maintain MTP activity to 
promote apoB100 lipidation (Bradbury et al., 1999). In this study, 
we provide evidence that PDI1 not only is important for MTP activ-
ity but also plays a key independent role in apoB100 oxidative 
folding. This conclusion is based on several sets of observations. 
First, Pdi1 knockdown reduced secretion of apoB100, which could 
be explained by either decreased apoB100 synthesis or acceler-
ated apoB100 degradation. Second, Pdi1 knockdown reduced 
apoB100 lipidation, which was, at least in part, attributable to de-
creased MTP activity. Third, Pdi1 knockdown selectively delayed 
disulfide bond formation in newly synthesized apoB100, which in 
turn affected apoB100 lipidation. Together these findings provide 
To confirm that the oxidative folding of apoB100 is dependent on 
PDI1, we stably expressed hemagglutinin (HA)-tagged wild-type hu-
man PDI1 (HA-PDI1) or a substrate-trap mutant of PDI1 (HA-PDI1CXXA) 
in McA cells (Rutkevich et al., 2010). We asked whether ectopic ex-
pression of human PDI1 can compensate for the delayed oxidation 
of apoB100 caused by Pdi1 knockdown in McA cells. Indeed, wild-
type human PDI1, but not the substrate-trap mutant, promoted 
apoB100 oxidative folding in Pdi1-knockdown cells, indicating that 
disulfide bond formation of apoB100 is dependent on, at least in 
part, the oxidoreductase activity of PDI1 (Figure 4C). Although over-
expression of wild-type human PDI1 appears to increase intracellular 
retention of albumin and transferrin, it does not affect their oxidative 
folding as it does for apoB100. Therefore the oxidoreductase activity 
of PDI1 is specifically required for apoB100 oxidative folding.
To test further whether PDI1 improves the oxidative folding of 
apoB100 independent of MTP activity, we treated McA cells with an 
MTP inhibitor, CP-10447 (Pan et al., 2002), at 0, 0.3, and 3 μM and 
analyzed the oxidative folding of apoB100 as before (Figure 4D). 
The MTP inhibitor decreased intracellular recovery of apoB100 in 
McA cells as previously described (Fukuda et al., 1983). However, it 
did not increase the amount of partially oxidized apoB100 com-
pared with that observed upon Pdi1 knockdown (Figure 4D). There-
fore PDI1 plays both MTP-dependent and MTP-independent roles 
in apoB100 synthesis and VLDL assembly.
PDI1 promotes apoB100 lipidation in McA cells
To confirm that apoB100 is a substrate for PDI1, we analyzed the 
apoB100 protein complex in Pdi1-knockdown McA cells that stably 
express either HA-PDI1 or HA-PDI1CXXA as described before. Cell 
lysates were immunoprecipitated using apoB antibody, and the im-
munocomplexes were analyzed by SDS–PAGE under nonreducing 
conditions, followed by immunoblotting with anti-HA antibody. If 
apoB100 is a substrate of PDI1, the substrate-trap mutant of PDI1 
should be present in covalent association with apoB100 under 
nonreducing conditions. Indeed, we detected HA-PDI1CXXA in the 
apoB100 immunocomplex under nonreducing conditions (Figure 5A), 
indicating that the cysteines of the CXXA motif in substrate-trap mu-
tant PDI1 can form disulfide bonds with cysteine residues of 
apoB100. This observation indicates that PDI1 promotes formation 
of disulfide bonds in apoB100 via intermolecular disulfide bonds. 
Thus PDI1 is important for stabilizing apoB100 structure by serving 
as a thiol-disulfide oxidoreductase.
To examine further whether reduced apoB100 oxidative folding 
could affect apoB100 lipidation in Pdi1-knockdown McA cells, we 
analyzed the DGUC-fractionated, apoB100-containing lipoprotein 
particles from the media using nonreducing gels. We found that 
oxidized apoB100 secreted by the control McA cells mainly 
migrated in fractions 1 and 2, which are associated with more 
abundant lipids, whereas reduced or partially oxidized apoB100 
secreted by Pdi1-knockdown McA cells predominantly migrated in 
the lipid-poor fractions (fractions 4–6; Figure 5, C and D). On the 
basis of these findings, we conclude that PDI1-mediated apoB100 
oxidative folding may facilitate apoB100 lipidation and in turn miti-
gate cotranslational and posttranslational degradation.
DISCUSSION
Disturbances of hepatic lipid metabolism from a variety of path-
ways may lead to excessive production of VLDL particles, which in 
turn contribute to atherogenic lipid and lipoprotein abnormalities 
(Dobiasova and Frohlich, 2001). ApoB100 is the key structural pro-
tein of VLDL, and a better understanding of the apoB100 folding 
and VLDL assembly process should provide new insights and 
FIGURE 5: Reduced apoB100 oxidative folding decreases apoB 
lipidation. (A) PDI1 forms intermolecular disulfide bond(s) with 
apoB100. Lysates from cells that stably express HA-tagged wild-type 
(Pw: HA-PDI1) or substrate-trap mutant (Pc: HA-PDICXXA) of human 
PDI1 were immunoprecipitated with apoB100 antibody and analyzed 
by nonreducing SDS–PAGE and immunoblotting against HA antibody. 
The circle indicates PDI1 complexed with apoB100. IP, immuno-
precipitated protein complex; T, total cell lysates. (B) Impaired 
apoB100 oxidative folding decreases apoB100 lipidation. Secreted 
apoB100-containing lipoproteins from McA cells were separated by 
DGUC as described in Figure 3 and analyzed by nonreducing gel 
electrophoresis. (C) The amount of apoB100 in each fraction was 
quantified by ImageJ. Relative distributions were calculated according 
to the percentage of apoB100 in each fraction relative to its total 
intensity across the gel.
PW-T PC-T PW-IP PC-IP  PW-T PC-T PW-IP PC-IP




IP-apoB; IB: HA             IP-apoB; IB: apoB














































Reducing gel                 Non-Reducing gel
Ox
Re




























































C.                                                                                                  
Density (g/ml) Density (g/ml)
a                                     b
602 | S. Wang et al. Molecular Biology of the Cell
In summary, our results provide new insight into the requirements 
and pathways for apoB100 folding and VLDL assembly and identify 
PDI1 as a critical isomerase for disulfide bond formation in apoB100. 
Given that PDI1 is an essential molecule for apoB100 synthesis and 
VLDL assembly, PDI1 inhibitors may provide an additional alterna-
tive to MTP inhibitors, antisense to apoB100, or inhibition of PCSK9 
in treating hyperlipidemia (Koren et al., 2014), especially in individu-
als who do not respond well to statin therapy (Ahmad, 2014).
MATERIALS AND METhODS
Materials
Easytag radiolabel [35S]Cys/Met was from PerkinElmer (Waltham, 
MA), and [3H]glycerol was from American Radiolabeled Chemicals 
(St. Louis, MO). Antibody against human and rodent apoB was from 
Millipore (Billerica, MA, AB742); antibodies against albumin, trans-
ferrin, and tubulin were from Sigma-Aldrich (St. Louis, MO; A0433, 
T2027, A2228). Antibodies against GFP, MTP, and BiP were from BD 
Transduction Laboratories (Carlsbad, CA; 632375, 612022, 610979); 
antibodies against PDI1, caspase 3, and PARP were from Cell Signal-
ing (Boston, MA; 3501, 9665, 9532); antibody against eIF2α-P was 
from Fisher Scientific (Carlsbad, CA; 44-728G); antibody against 
CHOP was from Santa Cruz Biotechnology (Santa Cruz, CA; SC-793). 
The MTP inhibitor, CP-10447, was purchased from Sigma-Aldrich.
Mammalian cell culture
Murine Hepa1-6 cells and rat McA-RH7777 hepatoma (McA) cells 
were obtained from the American Type Culture Collection (Manassas, 
VA) and maintained in DMEM (Corning, Corning, NY) with 10% fetal 
bovine serum (FBS) at 37°C in 5% CO2. The cells were passaged 
every other day. Both Hepa1-6 and McA cells were used to study 
the effect of PDI1 knockdown on the ER stress response. Cells were 
treated with different concentrations of Tm and Tg. Cell survival was 
measured by Cell Counting Kit-8 (Dojindo Molecular Technologies, 
Rockville, MD). McA cells that stably express HA-tagged wild-type 
(HA-PDI1) or the substrate-trap mutant of human PDI1 (HA-PDI1CXXA; 
Rutkevich et al., 2010) were generated by infection with retroviruses 
expressing each protein, followed by selection for G418 resistance 
(400 μg/ml). To generate McA cells that stably express Grx-roGFP-
iEER (Birk et al., 2013), cells were transfected with plasmid DNA and 
selected for growth in G418 (400 μg/ml).
Adenovirus constructs
Two independent adenoviruses expressing shRNAs were con-
structed to target the sequences 5′-GGCTTCAAGGGCAA-
GATCCT-3′ and 5′-GGCGAACTTTGAAGAGGTCGC-3′ in PDI1. 
The nonspecific Ad-NS shRNA sequence was previously reported 
(Herzig et al., 2001).
RNA isolation and quantitative reverse transcription PCR
Total RNA was isolated from cells using Isol-RNA lysis reagent 
(Fisher Scientific, Carlsbad, CA). cDNA synthesis from total RNA 
was performed using iScript Reverse Transcription Supermix for 
quantitative reverse transcription PCR (Bio-Rad, Hercules, CA). 
All primers were synthesized by Integrated DNA Technologies 
(Coralville, IA). Primer sequences (5′ → 3′) were as follows: PDI1-a: 
forward, TCTGAGATTCGACTAGCAAAGGT, and reverse, GCCA-
CGGACACCATACTGC; PDI1-b: forward, CCGTGGCTACCCCA-
CAATC, and reverse, GCAGTGTCAGACAGGGTTGTA; ERp57: 
forward, CGCCTCCGATGTGTTGGAA, and reverse, CAGTG-
CAATCCACCTTTGCTAA; ERp72, forward, AGTCAAGGTGGTG-
GTGGGAAAG, and reverse, TGGGAGCAAAATAGATGGTAGGG; 
GRP94: forward, AATAGAAAGAATGCTTCGCC, and reverse, 
new insight into the apoB100 oxidative folding process, which is 
tightly connected with apoB100 lipidation and lipid-rich VLDL 
assembly.
McA cells are widely used as a model for studying lipoprotein 
secretion because it is a cell line most similar to human hepatocytes 
in secretion of TG-rich VLDL (Boren et al., 1994; Ota et al., 2008). 
Here we knocked down Pdi1 in McA cells to explore the role for 
PDI1 in apoB100 oxidative folding and lipidation. We were able to 
distinguish apoB100 proteins with different oxidative folding 
states—complete to partially oxidized to reduced—based on the 
differential migration pattern on nonreducing gels, which was not 
previously described. However, because apoB100 contains eight 
disulfide bonds (Burch and Herscovitz, 2000), we were not able to 
identify how many disulfides are native or whether all of the apoB100 
that migrated with the oxidized form contains the same number 
and/or correct pairing of disulfide bonds. Nevertheless, the migra-
tion pattern of apoB100 under nonreducing conditions was differ-
ent between control and Pdi1-knockdown cells, indicating that PDI1 
plays an indispensable role in the proper oxidation of at least some 
disulfide bonds. Previous studies showed that the disulfide bond 
involving cysteines 7 and 8 (residues 242 and 258, respectively) is 
most important for VLDL assembly and secretion (Tran et al., 1998). 
Because the reduced apoB100 appeared to be less lipidated in 
Pdi1-knockdown cells, our findings raise the interesting possibility 
that PDI1 could catalyze the disulfide bond formation between 
cysteines 7 and 8 (Tran et al., 1998).
Previous studies implicated both nonenzymatic and enzymatic 
roles of PDI1 in apoB100 lipidation and secretion (Wang et al., 
1997). Here we provide direct evidence to pinpoint the dual role of 
PDI1 in apoB100 synthesis and secretion. PDI1 was characterized in 
the MTP complex to retain functional MTP in the ER to aid in 
apoB100 lipidation (Bradbury et al., 1999). We indeed observed de-
creased MTP activity in Pdi1-knockdown cells, which was restored 
by either wild-type PDI1 or a catalytically inactive form of PDI1, indi-
cating a nonenzymatic requirement for PDI1 in regulation of MTP 
activity. On the other hand, we found that PDI1 also promotes oxi-
dative folding of apoB100, indicating an enzymatic requirement for 
PDI1 in apoB100 synthesis and folding. The dual role of PDI1 cou-
ples apoB100 folding with lipidation so that efficient apoB100 lipi-
dation either proceeds, is coincident with, or occurs immediately 
after proper disulfide bond formation in apoB100. Although it is not 
known whether PDI1 oxidizes apoB independently or in a complex 
with MTP, our findings suggest that PDI1 is an essential component 
for both apoB100 folding and lipidation.
The ER is the organelle where both apoB100 synthesis and lipi-
dation occur (Wang and Kaufman, 2014). The ER lumen provides an 
optimal redox milieu for proper folding of apoB100 and an ade-
quate lipid store for VLDL maturation (Rusinol et al., 1993). Recently, 
we reported that ER homeostasis maintained by the inositol-requir-
ing transmembrane kinase/endoribonuclease 1α (IRE1α)-X-box–
binding protein 1 (XBP1) arm of the UPR is important for lipid-rich 
VLDL assembly (Wang et al., 2012). The present study underscores 
our earlier conclusions that ER homeostasis plays a critical role in 
apoB100 folding to support the formation of disulfide bonds in 
apoB100. PDI1 appears to be the protein disulfide isomerase that 
catalyzes formation of disulfide bonds that are critical for apoB100 
folding and lipidation. This conclusion is further supported by the 
observation that apoB100 forms an intermolecular disulfide with 
PDI1. However, the liver contains additional members of the PDI 
family, including ERp57 and ERp72 (Grubb et al., 2012). Their func-
tions in catalyzing disulfide bond formation or rearrangement still 
need to be established.
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MTP activity assay
MTP activity was measured in McA cells using MTP Activity Assay Kit 
(Roar Biomedical, New York, NY) based on the published protocol 
(Athar et al., 2004; Wang et al., 2012).
Measurement of oxidative folding of apoB100 in McA cells
McA cells were treated with puromycin (100 μM) for 10 min before 
labeling with 140 μCi/ml [35S]Met/Cys to synchronize protein syn-
thesis. Cells were incubated in PBS containing 25 mM NEM for 
10 min and lysed in RIPA buffer containing 25 mM NEM. Cell lysates 
were immunoprecipitated with apoB antibody, and labeled apoB 
immunocomplexes were analyzed by 5% SDS–PAGE. The post-IP 
supernatants were used for immunoprecipitating albumin and trans-
ferrin and run on 7.5% SDS–PAGE under nonreducing conditions 
(Rutkevich et al., 2010).
Statistical analyses
Data in the figures are presented as mean ± SEM, applying the un-
paired two-tailed t test. p < 0.01 is considered to be a significant 
difference.
TCTTCAGGCTCTTCTTCTGG; apoB: forward, CAAGCACCTCCG-
AAAGTA, and reverse, CACGGTATCCAGGAACAA; MTP: forward, 
GCCCTAGTCAGGAAGCTGTG, and reverse, CCAGCAGGTACAT-
TGTGGTG; XBP1 (spliced): forward, AAGAACACGCTTGGGAA-
TGG, and reverse, CTGCACCTGCTGCGGAC; ERdj4: forward, 
TTAGAAATGGCTACTCCACAGTCA, and reverse, TTGTCCTGAA-
CAATCAGTGTATGTAG; and P58IPK: forward, TCCTGGTGGACCT-
GCAGTACG, and reverse, CTGCGAGTAATTTCTTCCCC.
Protein isolation and Western blotting
Cells were lysed, and proteins were extracted using RIPA buffer (50 
mM Tris-HCl, pH 7.4, buffer containing 1% Triton X-100, 0.5% so-
dium deoxycholate, and 0.5 mM EDTA). Proteins were separated by 
electrophoresis on criterion Tris-HCl gels (Bio-Rad, Hercules, CA) 
and electroblotted onto polyvinylidene fluoride membranes, which 
were blocked with nonfat dry milk. Membranes were then incubated 
with different primary antibodies (see Materials). The membranes 
were further incubated with appropriate horseradish peroxidase–
conjugated secondary antibodies to develop the image using ECL 
reagents (Fisher Scientific, Carlsbad, CA).
Dithiothreitol recovery experiments
Cells were pretreated with 10 mM DTT in normal growth medium 
for 10 min at 37°C. Cells were then washed with phosphate-buffered 
saline (PBS) twice, followed by incubation with growth medium for 
2, 5, and 10 min before collecting them in PBS containing 20 mM 
NEM for 20 min on ice. Cells were lysed using RIPA buffer contain-
ing 25 mM NEM, and lysates were analyzed by 12% SDS–PAGE 
under nonreducing conditions, followed by Western blotting analy-
sis (Birk et al., 2013).
Pulse-chase analysis of apoB in McA cells
McA cells were incubated in media containing 0.4 mM bovine 
serum albumin (BSA)–conjugated oleic acid (OA) for 4 h before 
and during the entire duration of the pulse-chase experiment. 
Cells were incubated in Met- and Cys-free medium for 15 min, 
followed by 15-min labeling with 140 μCi/ml [35S]Met/Cys and 
25- and 50-min chase in medium containing excess unlabeled 
Met and Cys (final concentration of 5 mM). After chase, both me-
dia and cell lysates were harvested for immunoprecipitation (IP) 
with apoB antibody. Labeled apoB immunocomplexes were ana-
lyzed by SDS–PAGE and exposed to a phosphoimager screen for 
autoradiography. Quantification was performed using ImageJ 
(Collins, 2007).
VLDL-TG synthesis and secretion in McA cells
TG synthesis and secretion were measured in McA cells by incuba-
tion for 3 h with OA (0.4 mM) and [3H]glycerol (1 μCi/ml). Labeled 
TG was extracted from both cells and media, separated by TLC, 
and analyzed by scintillation counting as described (Chen et al., 
2010).
Density gradient analysis of secreted lipoproteins 
from McA cells
McA cells were exposed to 140 μCi/ml [35S]Met/Cys containing BSA 
(1.5%) or BSA-OA (400 μM) for 4 h. The density of labeled media 
was adjusted to 1.25 g/ml using KBr and layered below a KBr/NaCl 
solution with densities of 1.063, 1.019, and 1.006 g/ml (Chen et al., 
2010). Lipoproteins were separated in the gradient by ultracentrifu-
gation at 38,000 rpm overnight. Eleven fractions were harvested, 
immunoprecipitated with apoB antibody, and analyzed as described 
for pulse-chase analysis (Wang et al., 2012).
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